150 related articles for article (PubMed ID: 15337549)
21. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer.
Rödel C; Liersch T; Hermann RM; Arnold D; Reese T; Hipp M; Fürst A; Schwella N; Bieker M; Hellmich G; Ewald H; Haier J; Lordick F; Flentje M; Sülberg H; Hohenberger W; Sauer R
J Clin Oncol; 2007 Jan; 25(1):110-7. PubMed ID: 17194912
[TBL] [Abstract][Full Text] [Related]
22. Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' follow-Up.
Fernández-Martos C; Aparicio J; Bosch C; Torregrosa M; Campos JM; Garcera S; Vicent JM; Maestu I; Climent MA; Mengual JL; Tormo A; Hernandez A; Estevan R; Richart JM; Viciano V; Uribe N; Campos J; Puchades R; Arlandis F; Almenar D
J Clin Oncol; 2004 Aug; 22(15):3016-22. PubMed ID: 15210740
[TBL] [Abstract][Full Text] [Related]
23. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.
Rödel C; Grabenbauer GG; Papadopoulos T; Hohenberger W; Schmoll HJ; Sauer R
J Clin Oncol; 2003 Aug; 21(16):3098-104. PubMed ID: 12915600
[TBL] [Abstract][Full Text] [Related]
24. Phase I study of oxaliplatin in combination with capecitabine and radiotherapy as postoperative treatment for stage II and III rectal cancer.
Jin J; Li YX; Wang JW; Wang WH; Liu YP; Wang K; Fang H; Zhou ZX; Zhou AP; Yu ZH
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):671-7. PubMed ID: 18455328
[TBL] [Abstract][Full Text] [Related]
25. Pre-operative radiochemotherapy with raltitrexed for resectable locally-advanced rectal cancer: a phase II study.
Leonardi MC; Zampino MG; Luca F; Jereczek-Fossa BA; Petazzi E; Tatani B; Lazzari R; Biffi R; Lorizzo K; Magni E; Scanniffio D; Orsi F; Bonomo G; Petralia G; Trovato C; Crosta C; Andreoni B; Orecchia R
Anticancer Res; 2006; 26(3B):2419-23. PubMed ID: 16821626
[TBL] [Abstract][Full Text] [Related]
26. Oxaliplatin plus dual inhibition of thymidilate synthase during preoperative pelvic radiotherapy for locally advanced rectal carcinoma: long-term outcome.
Avallone A; Delrio P; Pecori B; Tatangelo F; Petrillo A; Scott N; Marone P; Aloi L; Sandomenico C; Lastoria S; Iaffaioli VR; Scala D; Iodice G; Budillon A; Comella P
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):670-6. PubMed ID: 20472346
[TBL] [Abstract][Full Text] [Related]
27. Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials.
Weiss C; Arnold D; Dellas K; Liersch T; Hipp M; Fietkau R; Sauer R; Hinke A; Rödel C
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):472-8. PubMed ID: 20133081
[TBL] [Abstract][Full Text] [Related]
28. A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer.
Kundel Y; Brenner B; Symon Z; Oberman B; Sadezki S; Koller M; Catane R; Pfeffer R
Anticancer Res; 2007; 27(4C):2877-80. PubMed ID: 17695464
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
[TBL] [Abstract][Full Text] [Related]
30. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
[TBL] [Abstract][Full Text] [Related]
31. Raltitrexed plus oxaliplatin in the second-line treatment of metastatic colorectal cancer.
Vyzula R; Kocáková I; Demlová R; Kiss I; Dusek L; Jarkovský J
Neoplasma; 2006; 53(2):119-27. PubMed ID: 16575467
[TBL] [Abstract][Full Text] [Related]
32. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
[TBL] [Abstract][Full Text] [Related]
33. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
[TBL] [Abstract][Full Text] [Related]
34. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M
Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571
[TBL] [Abstract][Full Text] [Related]
35. Addition of oxaliplatin to neo-adjuvant radiochemotherapy for irresectable rectal cancer, a phase I study.
Reerink O; Mulder NH; Verschueren RC; Wiggers T; Szabo BG; Hospers GA
Anticancer Res; 2005; 25(1B):629-33. PubMed ID: 15816638
[TBL] [Abstract][Full Text] [Related]
36. Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study.
Picardi V; Deodato F; Guido A; Giaccherini L; Macchia G; Gambacorta MA; Arcelli A; Farioli A; Cellini F; Cuicchi D; DI Fabio F; Poggioli G; Ardizzoni A; Frezza G; Cilla S; Caravatta L; Valentini V; Fuccio L; Morganti AG
Anticancer Res; 2016 Aug; 36(8):4081-7. PubMed ID: 27466517
[TBL] [Abstract][Full Text] [Related]
37. Preoperative chemoradiation with oral tegafur within a multidisciplinary therapeutic approach in patients with T3-4 rectal cancer.
Díaz-González JA; Calvo FA; Cortés J; de La Mata D; Gómez-Espí M; Lozano MA; Lozano E; Serrano J; Herranz R
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1378-84. PubMed ID: 15817340
[TBL] [Abstract][Full Text] [Related]
38. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A
J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495
[TBL] [Abstract][Full Text] [Related]
39. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation.
Valentini V; Coco C; Cellini N; Picciocchi A; Genovesi D; Mantini G; Barbaro B; Cogliandolo S; Mattana C; Ambesi-Impiombato F; Tedesco M; Cosimelli M
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1067-75. PubMed ID: 9539561
[TBL] [Abstract][Full Text] [Related]
40. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]